CompletedNot Applicable

Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia

France236 participantsStarted 2017-06-12

Plain-language summary

The aim of the study is to setup a collection of maternal plasma and serum from patients with preeclampsia and normal pregnancy for in vitro validation of new therapeutics based on extra-corporal removal of sFlt-1

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age from 18 to 50 years old * Singleton pregnancies between 20 and 41 weeks of gestation * Preeclampsia * Normal pregnancy Exclusion Criteria: * Age\<18 * Infectious disease: HIV, HBV or HCV * Multiple pregnancies * Opposition of the patient

What they're measuring

ratio sFlt-1/PlGF

Timeframe: Day 0

Trial details

NCT IDNCT03188900

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-06-12

View on ClinicalTrials.gov More Preeclampsia trials